Incidence of neonatal abstinence syndrome triples in USBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4476 (Published 15 August 2016) Cite this as: BMJ 2016;354:i4476
- Michael McCarthy
The incidence of neonatal abstinence syndrome, primarily because of in utero exposure to opioids, increased by almost 300% from 1999 to 2013, rising from 1.5 to 6.0 cases per 1000 hospital births, researchers from the US Centers for Disease Control and Prevention (CDC) have found.1
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial